-
InnoCare Appoints Xin Fu as Chief Financial Officer
PharmaSources
December 18, 2023
InnoCare Pharma, announced today that the Company appointed Mr. Xin Fu, who has extensive finance-related experience, as the Chief Financial Officer.
-
4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection
B3C newswire
November 06, 2023
In a significant financial milestone, Xlife Sciences AG invests CHF 23.3 million in 4D Lifetec AG, acquiring a 20% stake in the company.
-
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
PharmaSources.com
May 05, 2022
Avantor announced it will create a new manufacturing and distribution Hub in Singapore.
-
2021 — the year UK biotechs broke investment records
CPhIonline
February 10, 2022
Initial Public Offerings totalled £1,304 million, an increase of 434% from 2020, but more needs to be done to connect the UK's life sciences and finance sectors.
-
Coller Capital And Ping An Overseas Holdings Announce Closure Of One Of The World's Largest Private Credit Secondaries Transaction
prnasia
August 04, 2021
Coller Capital and Ping An Overseas Holdings together with its subsidiaries, the main offshore investment and asset management platform of Ping An Insurance (Group) Company of China, Ltd., have closed one of the world's largest private credit ...
-
Sanofi invests 50 million euros in Jeito Capital
expresspharma
November 16, 2020
The investment will be deployed by Jeito’s team, in line with its investment criteria, to support French and European healthcare entrepreneurs.
-
Recipharm Invests €2.6M in Kaysersberg Facility
contractpharma
October 16, 2020
The Kaysersberg facility specializes in producing sterile liquids for therapeutic areas including eye care and ear drops.
-
UK biotech companies raise over £1bn in record quarter
pharmatimes
October 15, 2020
In new data published by the BioIndustry Association (BIA) and Clarivate, UK biotech companies reportedly raised over £1bn in equity finance between June and August 2020.
-
Catalent Invests $50M at Bloomington Facility
contractpharma
September 03, 2020
To install an additional high-speed vial filling line to support growing pipeline of clinical programs and commercial launches at the site.
-
Sekisui Invests $18.93 Million in Biopharma CDMO Business
contractpharma
August 03, 2020
Sekisui has invested £14.4 million ($18.93 million) in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022.